Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)

ClinicalTrials.gov ID: NCT00577473

Public ClinicalTrials.gov record NCT00577473. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, 6 Week, Parallel-group Design Clinical Trial in Patients With Mildly to Moderately Active Ulcerative Colitis to Assess the Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day

Study identification

NCT ID
NCT00577473
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Warner Chilcott
Industry
Enrollment
301 participants

Conditions and interventions

Interventions

  • mesalamine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2001
Primary completion
Jan 31, 2003
Completion
Jan 31, 2003
Last update posted
Sep 15, 2011

2001 – 2003

United States locations

U.S. sites
44
U.S. states
24
U.S. cities
44
Facility City State ZIP Site status
Research Site Birmingham Alabama
Research Site Anaheim California
Research Site Sacramento California
Research Site San Francisco California
Research Site Denver Colorado
Research Facility Golden Colorado
Research Site Bridgeport Connecticut
Research Site Fort Myers Florida
Research Site Hollywood Florida
Research Site Jupiter Florida
Research Site Miami Florida
Research Facility Atlanta Georgia
Research Facility Decatur Georgia
Research Site Arlington Heights Illinois
Research Site Moline Illinois
Research Site Rockford Illinois
Research Site Wichita Kansas
Research Site Metairie Louisiana
Research Site Baltimore Maryland
Research Site Laurel Maryland
Research Site Detroit Michigan
Research Site New Brunswick New Jersey
Research Site Somerville New Jersey
Research Site Great Neck New York
Research Site Pomona New York
Research Facility Poughkeepsie New York
Research Site Raleigh North Carolina
Research Site Winston-Salem North Carolina
Research Site Cincinnati Ohio
Research Site Tulsa Oklahoma
Research Site Philadelphia Pennsylvania
Research Site Pittsburgh Pennsylvania
Research Site Charleston South Carolina
Research Facility Memphis Tennessee
Research Facility Nashville Tennessee
Research Site Fort Worth Texas
Research Site Houston Texas
Research Site San Antonio Texas
Research Site Burlington Vermont
Research Site Charlottesville Virginia
Research Facility Falls Church Virginia
Research Site Norfolk Virginia
Research Site Tacoma Washington
Research Site Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00577473, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2011 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00577473 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →